Analysts' Upgrades, Downgrades: Level 3 Communications

Change in Ratings

Alcatel-Lucent(ALU Quote - Cramer on ALU - Stock Picks) upgraded at Merrill to neutral with a $7.24 price target. Risk/reward within the stock is now more balanced vs. other tech names. Earnings estimates and fundamentals remain unchanged.

Atheros(ATHR Quote - Cramer on ATHR - Stock Picks) upgraded at Piper from neutral to buy with a $34 price target. Channel checks suggest that the company is taking more market share. Estimates remain above consensus.

Compellent Technologies(CML Quote - Cramer on CML - Stock Picks) downgraded at RBC to sector perform from outperform. Price target holds at $13 and reiterates speculative risk assessment.

Huntsman(HUN Quote - Cramer on HUN - Stock Picks) upgraded at Jefferies. Rating raised to hold from underperform. Maintains 2008 EPS estimates of 70 cents and $11 price target.

Interpublic Group(IPG Quote - Cramer on IPG - Stock Picks) initiated at UBS with a neutral rating and $9.50 price target. Introduces 2008 EPS estimates of 43 cents.

Level 3 Communications(LVLT Quote - Cramer on LVLT - Stock Picks) downgraded at Citigroup from hold to sell. The retreat within the telecom valuations increases the downside risk for the share price.

Myriad Genetics(MYGN Quote - Cramer on MYGN - Stock Picks) upgraded at RBC to sector perform from underperform. Price target holds at $13 and reiterates above average risk assessment.

Omnicom Group(OMC Quote - Cramer on OMC - Stock Picks) initiated at UBS with a neutral rating and $50 price target. Introduces 2008 EPS estimates of $3.30.

Powerwave(PWAV Quote - Cramer on PWAV - Stock Picks) upgraded at Goldman Sachs to buy from neutral. Believe investors are underestimating revenue potential and improvements in gross margins. See 10% or better revenue growth over next two to three years. Price target raised to $5.30 from $4.80.

Smithfield Foods(SFD Quote - Cramer on SFD - Stock Picks) upgraded at Morgan Stanley from underweight to equal-weight. Valuation call, as the stock is 18% below its $24 price target. Consensus estimates remain too optimistic, however.

« Previous Page

1 2

Next Page »